A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
The best Bull and Bear pitches based on recency and number of recommendations.
Though attractive target, but market is too enthusiastic about it's prospect of going north of 150. Thinking it may stay around $130 mark.
Read the most recent pitches from players about ONXX.DL.
Find the members with the highest scoring picks in ONXX.DL.
See what the Wall Street professionals think, according to their public statements and filings.